Event Detail (Archived)

Cardiovascular Research Institute Special Seminar

Human iPSC-Cardiomyocytes: A Drug-screening Platform for Precision Medicine

  • This event already took place in February 2017
  • A-950 WCMC, 1300 York Ave.

Event Details

Type
Other Tri-Institutional Events
Speaker(s)
Elena Matsa, Ph.D., instructor, Stanford Cardiovascular Institute, Stanford University
Open to
Public
Host
Geoffrey Pitt, M.D., Ph.D., CVRI Director
Contact
Silvia Santacruz
Phone
(646) 962-8429
Sponsor
Silvia Santacruz
(646) 962-8429
sis2014@med.cornell.edu

Related News

Some mammals can hit pause on a pregnancy. Understanding how that happens could help us treat cancer.

New study reveals the molecular brake that lets embryonic stem cells enter suspended animation, while retaining the ability to develop normally—which could shed light on abnormal cell growth in humans.

New engineered derivative of a natural molecule could translate into a powerful replacement for IVIG therapy for a wide array of autoimmune disorders

In experiments with mice, the new molecule accomplished the same job at a hundredth of the dose.

This new insight into T cell receptors may improve cancer immunotherapies

Researchers discovered that a crucial first step in the signaling system operates differently than previously thought, an insight that could lead to the next generation of treatments.

Related Events

Microscale Biophysics of the Ocean: A Single-Cell Perspective on the Biological Carbon Pump

| CARSON FAMILY AUDITORIUM (CRC)

Liquid Biopsies in Pediatric Solid Tumors

| CARSON FAMILY AUDITORIUM (CRC)

Spying on the Immune System

| CASPARY AUDITORIUM
The Philip Levine Memorial Lecture